12 /100
LOW RISK
Score updated Jul 14, 2026

UCIB — UBS ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B Dilution Risk Tracker

Track UCIB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track UCIB — Get alerts when the score changes →

As of July 14, 2026, UBS ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B (UCIB) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. UBS ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B has 3.86B shares outstanding.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for UCIB.
🔔 Track UCIB — Get forecast alerts →

💹 Market Data

Market CapN/A
Shares Outstanding3.86B
FloatN/A
CashN/A
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest1.9K
Days to Cover1.5
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

424B2 DEBT May 04, 2026
424B2 DEBT May 04, 2026
424B2 DEBT May 04, 2026
424B2 DEBT May 04, 2026
424B2 DEBT May 04, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for UCIB Shareholders

UBS ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B (UCIB) has a DilutionScore of 12/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for UCIB shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for UCIB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for UCIB alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track UCIB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking UCIB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for UCIB
📊 UCIB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 UCIB Signal Convergence & Dark Pool Activity — StonkWhisper 📄 UCIB Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.